PROM1 and glioblastoma: Assuming all the aforementioned, U87 TAMARA+ cells are expected to be positive (at least partially) for CD133 (Prominin-1), the commonly accepted marker of glioblastoma CSCs, and, thus, can be referred to as U87 CSCs.